Iron Overload in Patients With Chronic Liver Disease

. 2016 Nov;12(11):695-698.

Affiliations

Kris V Kowdley. Gastroenterol Hepatol (N Y). 2016 Nov.

. 2016 Nov;12(11):695-698.

¹ Director, Liver Care Network and Organ Care Research Swedish Medical Center Seattle, Washington.

No abstract available

References

1. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. American Association for the Study of Liver Diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328–343. - PMC - PubMed
1. Ko C, Siddaiah N, Berger J, et al. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int. 2007;27(10):1394–1401. - PubMed
1. Kowdley KV, Belt P, Wilson LA, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55(1):77–85. - PMC - PubMed
1. Price L, Kowdley KV. The role of iron in the pathophysiology and treatment of chronic hepatitis C. Can J Gastroenterol. 2009;23(12):822–828. - PMC - PubMed